| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $67K | — | — |
| Gross Profit | $67K | — | — |
| R&D Expense | $6K | +0.0% | — |
| SG&A Expense | $536K | +1694.0% | +1204.6% |
| Operating Income | -$701K | -171.6% | -242.4% |
| Interest Expense | $40K | +21.6% | +71.0% |
| Net Income | -$897K | -53.6% | -97.7% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $49K | +77.3% | +280.2% |
| Total Assets | $140K | +2.6% | -91.4% |
| Current Liabilities | $1.8M | +20.5% | +81.9% |
| Total Liabilities | $1.9M | +19.1% | +87.9% |
| Stockholders' Equity | -$1.7M | -20.7% | -378.8% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$443K | -78.2% | — |
| Capital Expenditures | $7K | +0.0% | — |
| Investing Cash Flow | -$7K | +0.0% | — |
| Financing Cash Flow | $465K | +73.7% | — |
| Free Cash Flow | -$449K | -76.3% | — |